This content is in French.
Combating antifungal-resistant oral candidiasis in HIV patients: current challenges and innovative solutions
2 décembre 2024
Oral Candidiasis (OC) remains one of the most prevalent opportunistic
infections among individuals living with HIV. Despite significant advancements
in antiretroviral therapy, the emergence of antifungal-resistant Candida
strains poses a serious challenge to effective disease management. This growing
concern underscores the urgent need for innovative therapeutic alternatives.
This study explores the prevalence and underlying mechanisms of antifungal resistance in HIV-positive patients with OC, while also proposing strategies to optimize treatment approaches.
This study explores the prevalence and underlying mechanisms of antifungal resistance in HIV-positive patients with OC, while also proposing strategies to optimize treatment approaches.
Focus on antifungal resistance
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Keyvanfar, A., et al. (2024). Drug-resistant oral candidiasis in patients with HIV infection: a systematic review and meta-analysis. BMC infectious diseases, 24(1), 546.
View the source
